{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:20:00Z","timestamp":1791181200965,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Microbiology"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    The phenotypes of single\u2010 (SKO) and double\u2010knockout (DKO) lines of dihydrofolate reductase\u2013thymidylate synthase (DHFR\u2013TS) of bloodstream\n                    <jats:italic>Trypanosoma brucei<\/jats:italic>\n                    were evaluated\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Growth of SKO\n                    <jats:italic>in vitro<\/jats:italic>\n                    is identical to wild\u2010type (WT) cells, whereas DKO has an absolute requirement for thymidine. Removal of thymidine from the medium triggers growth arrest in S phase, associated with gross morphological changes, followed by cell death after 60\u2003h. DKO is unable to infect mice, whereas the virulence of SKO is similar to WT. Normal growth and virulence could be restored by transfection of DKO with\n                    <jats:italic>T.\u2003brucei<\/jats:italic>\n                    DHFR\u2013TS, but not with\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    TS. As pteridine reductase (PTR1) levels are unchanged in SKO and DKO cells, PTR1 is not able to compensate for loss of DHFR activity. Drugs such as raltitrexed or methotrexate with structural similarity to folic acid are up to 300\u2010fold more potent inhibitors of WT cultured in a novel low\u2010folate medium, unlike hydrophobic antifols such as trimetrexate or pyrimethamine. DKO trypanosomes show reduced sensitivity to these inhibitors ranging from twofold for trimetrexate to &gt;10\u2003000\u2010fold for raltitrexed. These data demonstrate that DHFR\u2013TS is essential for parasite survival and represents a promising target for drug discovery.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2958.2008.06305.x","type":"journal-article","created":{"date-parts":[[2008,6,16]],"date-time":"2008-06-16T06:13:51Z","timestamp":1213596831000},"page":"520-533","source":"Crossref","is-referenced-by-count":62,"title":["Chemical and genetic validation of dihydrofolate reductase\u2013thymidylate synthase as a drug target in African trypanosomes"],"prefix":"10.1111","volume":"69","author":[{"given":"Natasha","family":"Sienkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Jaros\u0142awski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Fairlamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0921-4410(03)21001-2","article-title":"Thymidylate synthase inhibitors","volume":"21","author":"Ackland S.P.","year":"2003","journal-title":"Cancer Chemother Biol Response Modif"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg481"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986706775476043"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg481"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000915)87:6<771::AID-IJC2>3.0.CO;2-V"},{"key":"e_1_2_6_7_1","first-page":"2548","article-title":"Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug\u2010induced inhibition of de novo thymidylate and purine biosynthesis in CCRF\u2010CEM cell lines","volume":"5","author":"Barnes M.J.","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11442"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1112642"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/cr00062a002","article-title":"Structure\u2013activity relationships of dihydrofolate reductase inhibitors","volume":"84","author":"Blaney J.M.","year":"1984","journal-title":"Chem Rev"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04541"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208374200"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05332.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161207780162827"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/348171a0"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7170"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.4.1599"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05332.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-7679-8_6"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2007.08.019"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(95)00059-A"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161207780162827"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/0929867053363432","article-title":"Novel chemical strategies for thymidylate synthase inhibition","volume":"12","author":"Gmeiner W.H.","year":"2005","journal-title":"Curr Med Chem"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444999008999"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/88584"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/80.4.911"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/expr.1997.4207","article-title":"Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways","volume":"87","author":"Hardy L.W.","year":"1997","journal-title":"Exp Parasitol"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.2307\/3282883"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/jb.170.7.3040-3045.1988","article-title":"Construction of a dihydrofolate reductase\u2010deficient mutant of Escherichia coli by gene replacement","volume":"170","author":"Howell E.E.","year":"1988","journal-title":"J Bacteriol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/nar\/24.5.992","article-title":"Quantitation of DNA fragmentation in apoptosis","volume":"24","author":"Ioannou Y.A.","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"e_1_2_6_31_1","first-page":"1959","article-title":"Expression of a folate binding\u2010protein in L1210 cells grown in low folate medium","volume":"49","author":"Jansen G.","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.46.30189"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0021-9258(17)42427-6","article-title":"The influence of extracellular folate concentration on methotrexate uptake by human KB cells \u2013 partial characterization of a membrane\u2010associated methotrexate binding\u2010protein","volume":"261","author":"Kane M.A.","year":"1986","journal-title":"J Biol Chem"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2000.01721.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444999008999"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986706775476043"},{"key":"e_1_2_6_37_1","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1021\/bi972693a","article-title":"Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence","volume":"37","author":"Luba J.","year":"1998","journal-title":"Biochemistry"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033453712"},{"key":"e_1_2_6_39_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1042\/BST0330983","article-title":"The myo\u2010inositol\u20101\u2010phosphate synthase gene is essential in Trypanosoma brucei","volume":"33","author":"Martin K.","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05216.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20051825"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00324a021"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(00)00369-8"},{"key":"e_1_2_6_44_1","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1017\/S0031182097001133","article-title":"New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity","volume":"114","author":"Nare B.","year":"1997","journal-title":"Parasitol"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.21.13883"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2004.02.013"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05216.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.38.3.476","article-title":"Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase","volume":"38","author":"Rathod P.K.","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_49_1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1128\/AAC.33.7.1090","article-title":"Selective activity of 5\u2010fluoroorotic acid against Plasmodium falciparum in vitro","volume":"33","author":"Rathod P.K.","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_50_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue\u00ae assay to determine drug sensitivity of African trypanosomes (T.b.rhodesiense and T.b.gambiense) in vitro","volume":"68","author":"Raz B.","year":"1997","journal-title":"Acta Trop"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2000.01721.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/AAC.49.8.3234-3238.2005","article-title":"Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: prospect for chemotherapy of Chagas' disease","volume":"49","author":"Senkovich O.","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2004.02.013"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.22.10267"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-05-0368"},{"key":"e_1_2_6_56_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008351221345","article-title":"Downstream molecular determinants of response to 5\u2010fluorouracil and antifolate thymidylate synthase inhibitors","volume":"11","author":"Van Triest B.","year":"2000","journal-title":"Ann Oncology"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(00)00369-8"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00007-8"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20051825"},{"key":"e_1_2_6_60_1","first-page":"3675","article-title":"Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors","volume":"61","author":"Van Der Wilt C.L.","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(99)00002-X"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.10.043"}],"container-title":["Molecular Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2958.2008.06305.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2958.2008.06305.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:24:10Z","timestamp":1695921850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2958.2008.06305.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1365-2958.2008.06305.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06305.x","archive":["Portico"],"relation":{},"ISSN":["0950-382X","1365-2958"],"issn-type":[{"value":"0950-382X","type":"print"},{"value":"1365-2958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}